Beyond Covid-19: What Should MedTech Innovators Expect?

After Covid-19 how will medical device product strategy change? Webinar with medtech commercialization experts

Perspectives on Medical Reimbursement By JR Associates   In recent months, the coronavirus pandemic (Covid-19) has dramatically disrupted businesses around the world. Arguably, healthcare has been more profoundly affected than any other industry. But even as attention remains focused on virus containment and treatment, medical technology companies must prepare for the long-term. “What next?” is…

Read More »

MDMA Reimbursement Conference Notes: 2019

MDMA Reimbursement Conference Notes 2019 - Top Takeaways from sessions at the Medical Device Manufacturers Association Healthcare Policy and Reimbursement Conference

Perspectives on Medical Reimbursement By JR Associates The Medical Device Manufacturers Association’s annual Coverage, Reimbursement and Health Policy Conference is always a high point on our firm’s schedule. That’s because our President, Judy Rosenbloom, and our VP of Global Health Policy, Jo Ellen Slurzberg, work hand-in-hand with MDMA each year to develop and deliver this educational event. Our relationship with…

Read More »

Can Innovation Solve the Healthcare Economics Crisis? Panel Notes

Can medical technology innovation solve the healthcare economics crisis? Read summary notes from this MDG Boston panel discussion

Perspectives on Medical Reimbursement By JR Associates   Recently, our VP of Global Health Policy, Jo Ellen Slurzberg moderated a compelling roundtable discussion at MDG Boston, a leading member-based community for medical device and technology professionals. This session focused on one of the industry’s most formidable issues: U.S. Healthcare Economics – Innovating Our Way Out of a…

Read More »

MDMA Reimbursement Conference Notes: 2018

MDMA Reimbursement Conference Notes 2018

Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…

Read More »

Medical Device Innovation and Reimbursement: MDMA 2016 Conference Notes

Read notes from MDMA Reimbursement Conference presentations 2016

Perspectives on Medical Reimbursement By JR Associates Through the years, our consultants have become popular as featured speakers at a variety of prestigious medical technology forums. But the highlight of our annual events calendar is always the MDMA Coverage, Reimbursement & Health Policy Conference. It is deeply rewarding to connect directly with medical device professionals and discuss critical…

Read More »

MDMA Reimbursement Conference Notes: 2015

Perspectives on Medical Reimbursement By JR Associates For years, our consultants have been featured speakers at the MDMA Annual Coverage, Reimbursement & Health Policy Conference — and the 2015 conference was no exception. Our Founder and President, Judy Rosenbloom, teamed with VP Health Policy, Jo Ellen Slurzberg, to share their expertise with the medical device manufacturing community in…

Read More »

What Should Life Sciences Startups Know About Reimbursement?

Reimbursement for Life Sciences Startups - JR Assocates VP Global Health Policy Jo Ellen Surzberg at Harvard Innovation Lab

Perspectives on Medical Reimbursement By JR Associates “Will my device be reimbursed?” This is one of the most important questions life sciences entrepreneurs must consider when developing new medical technology. But in today’s dynamic and complex healthcare environment, clear answers can be elusive. Harvard Innovation Lab recently invited our VP of Global Health Policy, Jo Ellen Slurzberg, to help clarify…

Read More »

Autism Investment Conference Session Notes

Jo Ellen Slurzberg_Reimbursement Strategies Autism Investment Conference

Perspectives on Medical Reimbursement By JR Associates Continuing its efforts to cultivate a marketplace of innovation that better serves those affected by autism, Autism Speaks recently hosted its third annual Autism Investment Conference in Boston. Our VP of Global Health Policy, Jo Ellen Slurzberg, was among the nearly 200 investors, entrepreneurs, healthcare advocates and corporate…

Read More »